Accretion Pharmaceuticals financial results announcements

Financial ResultsAccretion Pharmaceuticals Ltd ACCPLAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Accretion Pharmaceuticals H1 FY27 Results: Net Profit ₹8.2 Cr, Up 70.8% YoY

Accretion Pharmaceuticals reported unaudited standalone half-year results to 30 September 2026, with revenue of Rs 5,504.10 lakh and profit after tax of Rs 820.14 lakh. The results carry a limited review report from VSSB & Associates.

Key figure

Net profit ₹8.2 Cr · +70.8% YoY

Financial ResultsAccretion Pharmaceuticals Ltd ACCPL

Accretion Pharmaceuticals H2 FY26 Results: Net Profit ₹4.9 Cr, Up 14.0% YoY

Accretion Pharmaceuticals Ltd reported revenue from operations of ₹45.9 Cr (+18.3% YoY) and net profit of ₹4.9 Cr (+14.0% YoY) for H2 FY26.

Key figure

Net profit ₹4.9 Cr · +14.0% YoY

Financial ResultsAccretion Pharmaceuticals Ltd ACCPL

Accretion Pharmaceuticals Financial Results

Accretion Pharmaceuticals approved its FY26 audited financial results and appointed Ms. Bandana Kumari as HR Manager. Net profit for the period reached ₹9.67 Crore.